Curanex Pharmaceuticals CURX
NASDAQ CURX
$5.01 +0.39 (+8.43%)
As of: Oct 21, 2026 · 2:44 PM EDT

Curanex Pharmaceuticals (CURX) Net Cash Flow (2024 - 2025)

Updated

Curanex Pharmaceuticals' Net Cash Flow came in at -$857,404 for Q4 2025, compared with -$95,427 a year earlier.

Analysis

Curanex Pharmaceuticals (CURX) Net Cash Flow (2024 - 2025) Analysis & Trends

For FY2025, Curanex Pharmaceuticals' Net Cash Flow was $4.82 million.

  • Going back by year, Net Cash Flow was $74,525 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.72 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -1.27 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -2.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 1.53 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 757.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -3.94 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.95 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -4.43 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -722.00 Mn
10 Curanex Pharmaceuticals 7.11 Mn -6.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -857,404.00
Sep 30, 2025 5.72 Mn
Dec 31, 2024 -95,427.00
Sep 30, 2024 -129,943.00
API Access

Curanex Pharmaceuticals Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=CURX&period=max&api_key=YOUR_API_KEY